NEW NANOTHERAPY RESEARCH FOR INFLAMMATORY BOWEL DISEASES
THE NEW DEAL CONCEPT COULD REVOLUTIONIZE IBD THERAPIES FOR THE GREAT BENEFIT OF PATIENTS AND EUROPEAN HEALTHCARE SYSTEMS.
- Dr. Fabrice NAVARRO, New Deal Project Coordinator
THE PROJECT GOALS
THE PROJECT GOALS
The NEW DEAL project aims to develop a highly selective and local therapy with an improved efficacy and safety profile for IBD patients. This treatment might be an alternative to the existing therapies.
Design and validate a radically improved IBD therapy that specifically targets JAK1 / JAK3 inhibition by means of siRNA and RNAi interference.
Develop advanced technologies for delivering siJAK1 / siJAK3 locally to the inflamed gut
Promote the clinical translation and the future industrial transfer of this new clinical product for IBD therapy.
THE PROJECT NEWS
May New Deal Reads
Covid-19 and immunomodulation in IBD. Neurath MF, 2020. Gut; 0:1–8. The world is currently facing a coronavirus pandemic [...]
#MakeIBDwork: some useful tips for workers with IBD and their employers
May the 19th is the World IBD Day: a day when thousands of people unite and organise events [...]
IBD & Tea: A live Twitter debate on the future of inflammatory bowel disease
In the future, patients will receive personalised treatments for inflammatory bowel diseases. That’s the hope shared by Dr [...]
Nanoparticles for drug delivery
When scientists design a new drug to treat disease, they must choose how patients will take the medicine: [...]
THE PROJECT PARTNERS
THE PROJECT PARTNERS
